These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11374096)

  • 21. Absence of spinocerebellar ataxia type 3/Machado-Joseph disease within ataxic patients in the Czech population.
    Bauer PO; Zumrova A; Matoska V; Marikova T; Krilova S; Boday A; Singh B; Goetz P
    Eur J Neurol; 2005 Nov; 12(11):851-7. PubMed ID: 16241973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facial grimacing and clinical correlates in spinocerebellar ataxia type 3.
    Rezende Filho FM; Vale TC; Pedroso JL; Braga-Neto P; Barsottini OG
    J Neurol Sci; 2019 Feb; 397():138-140. PubMed ID: 30616057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between educational attainment and SCA 3 age of onset and disease course.
    Iannuzzelli K; Shi R; Carter R; Huynh R; Morgan O; Kuo SH; Bang J; Mills KA; Baranano K; Zee DS; Moukheiber E; Roda R; Butala A; Marvel C; Joyce M; Li X; Wang J; Rosenthal LS
    Parkinsonism Relat Disord; 2022 May; 98():99-102. PubMed ID: 35635856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6.
    Soong B W; Lu Y C; Choo K B; Lee H Y
    Arch Neurol; 2001 Jul; 58(7):1105-9. PubMed ID: 11448300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-ataxic manifestations of Spinocerebellar ataxia-2, their determinants and predictors.
    Stezin A; Venkatesh SD; Thennarasu K; Purushottam M; Jain S; Yadav R; Pal PK
    J Neurol Sci; 2018 Nov; 394():14-18. PubMed ID: 30196130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate CAG repeat lengths (53,54) for MJD/SCA3 are associated with an abnormal phenotype.
    van Alfen N; Sinke RJ; Zwarts MJ; Gabreëls-Festen A; Praamstra P; Kremer BP; Horstink MW
    Ann Neurol; 2001 Jun; 49(6):805-7. PubMed ID: 11409435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Copy number variation of trinucleotide repeat in dynamic mutation sites of autosomal dominant cerebellar ataxias related genes].
    Chen P; Ma M; Shang H; Su D; Zhang S; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Dec; 26(6):626-33. PubMed ID: 19953483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features.
    Dürr A; Stevanin G; Cancel G; Duyckaerts C; Abbas N; Didierjean O; Chneiweiss H; Benomar A; Lyon-Caen O; Julien J; Serdaru M; Penet C; Agid Y; Brice A
    Ann Neurol; 1996 Apr; 39(4):490-9. PubMed ID: 8619527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dystonia and ataxia progression in spinocerebellar ataxias.
    Kuo PH; Gan SR; Wang J; Lo RY; Figueroa KP; Tomishon D; Pulst SM; Perlman S; Wilmot G; Gomez CM; Schmahmann JD; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Parkinsonism Relat Disord; 2017 Dec; 45():75-80. PubMed ID: 29089256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of the different mutations causing spinocerebellar ataxia (SCA1, SCA2, MJD/SCA3 and DRPLA) in a large group of Brazilian patients.
    Lopes-Cendes I; Teive HG; Calcagnotto ME; Da Costa JC; Cardoso F; Viana E; Maciel JA; Radvany J; Arruda WO; Trevisol-Bittencourt PC; Rosa Neto P; Silveira I; Steiner CE; Pinto Júnior W; Santos AS; Correa Neto Y; Werneck LC; Araújo AQ; Carakushansky G; Mello LR; Jardim LB; Rouleau GA
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):519-29. PubMed ID: 9629399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics, Radiological Features and Gene Mutation in 10 Chinese Families with Spinocerebellar Ataxias.
    Chen JW; Zhao L; Zhang F; Li L; Gu YH; Zhou JY; Zhang H; Meng M; Zhang KH; Le WD; Dong CB
    Chin Med J (Engl); 2015 Jul; 128(13):1714-23. PubMed ID: 26112709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.
    Lee WY; Jin DK; Oh MR; Lee JE; Song SM; Lee EA; Kim GM; Chung JS; Lee KH
    Arch Neurol; 2003 Jun; 60(6):858-63. PubMed ID: 12810491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of CAG repeats at five different spinocerebellar ataxia loci: correlation and alternative explanations for disease pathogenesis.
    Alluri RV; Komandur S; Wagheray A; Chaudhuri JR; Sitajayalakshmi ; Meena AK; Jabeen A; Chawda K; Subhash K; Krishnaveni A; Hasan Q
    Mol Cells; 2007 Dec; 24(3):338-42. PubMed ID: 18182848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
    Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
    PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiological evaluation of spinocerebellar ataxias 1, 2 and 3.
    Yadav R; Pal PK; Krishna N; Amar BR; Jain S; Purushottam M
    J Neurol Sci; 2012 Jan; 312(1-2):142-5. PubMed ID: 21880333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in cortical excitability and central motor conduction time in spinocerebellar ataxias 1, 2 and 3: a comparative study.
    Jhunjhunwala K; Prashanth DK; Netravathi M; Jain S; Purushottam M; Pal PK
    Parkinsonism Relat Disord; 2013 Mar; 19(3):306-11. PubMed ID: 23219306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanded CAG repeats in spinocerebellar ataxia (SCA1) segregate with distinct haplotypes in South african families.
    Ramesar RS; Bardien S; Beighton P; Bryer A
    Hum Genet; 1997 Jul; 100(1):131-7. PubMed ID: 9225982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.